Plain-English translation of NCT07217912 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
After heart surgery, some patients experience confusion and difficulty sleeping during their hospital recovery. This trial is testing whether a medication called daridorexant—which helps improve sleep—might reduce confusion and help patients sleep better during the critical first three days after surgery. Half of the participants will receive the medication, and half will receive a placebo (a pill with no active ingredient), so researchers can see if the medication actually makes a difference.
Confusion after major heart surgery is common and can slow recovery and cause distress to patients and families. Since poor sleep is thought to contribute to this confusion, this medication—which is designed to improve sleep—may help prevent it from happening in the first place.
You likely qualify if…
You likely don't qualify if…
You will have a baseline visit before surgery to answer questions about your health and sleep. After your heart surgery, you will take either the study medication or a placebo pill for the first three nights in the hospital. Every day for the first three days after surgery, hospital staff will check on your sleep quality and watch for any signs of confusion. You will also have the option to wear a simple sleep monitor while in the hospital to help researchers understand your sleep patterns objectively. The whole study participation takes about three days during your hospital stay.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States